• What We Do
  • About Us
Logo Logo Logo Logo Logo
  • FAQ
  • Insights
  • Contact Us
  • What We Do
  • About Us
  • FAQ
  • Insights
  • Contact Us
 

Insights

Some of our public alerts on emerging trends…

  • Actos Mass Tort Ads Track Litigation Developments

    Author Imagethe215guys
    09 August, 2019
  • NY Political Scandal Highlights Competition for Asbestos Cases

    Author Imagethe215guys
    09 August, 2018
  • Skin cancer risk from ED drugs cited in plaintiffs’ firm ads

    Author Imagethe215guys
    09 August, 2017
  • Pradaxa Reemerges as Top Mass Tort Ad Target

    Author Imagethe215guys
    09 August, 2017
  • Zofran Ad Surge Signals Heightened Litigation Interest

    Author Imagethe215guys
    09 August, 2017
  • Infuse Bone Graft Ads Jump in January

    Author Imagethe215guys
    09 August, 2017

Sign up to receive our alerts on new developments:

Tags
AbbVie Alternative Litigation Financing AndroGel Asbestos Axiron Bayer Bloomberg Boehringer Ingelheim BP Cash Advances CW Davis & Crump Dialysis Eli Lily Environmental Contamination FDA Safety Advisory Fracking Fresenius Medical Center Goa Honnold Granuflo Gulf of Mexico Oil Spill Hemodialysis Hydraulic Fracturing Institute for Legal Reform Janssen Pharmaceuticals Jo Johnson & Johnson Lilly Low T Mesothelioma Meyer Blair NBC Pelvic Mesh Peter Angelos Pradaxa Pulaski & Middleman Renal Failure Riata Defibrillator Risperdal Simien & Simien St. Jude Medical Structured Settlements Testosteron Therapy WGN Xarelto
2020 Pennsylvania Ave NW Suite 144 Washington, DC 20006
202.930.ANTE (2683)
info@X-Ante.com
© 2021 X-Ante | Terms of Service / Privacy Policy | Website Design by The 215 Guys